|
breast cancer |
4 |
|
cytology |
4 |
|
endometrial carcinoma |
4 |
|
fine-needle aspiration |
4 |
|
immunohistochemistry |
4 |
|
breast |
3 |
|
cell block |
3 |
|
lung cancer |
3 |
|
phyllodes tumor |
3 |
|
biomarkers |
2 |
|
cancer |
2 |
|
cervical adenocarcinoma |
2 |
|
cervical smear |
2 |
|
cytological techniques |
2 |
|
diagnostic techniques and procedures |
2 |
|
digital pathology |
2 |
|
endometrial hyperplasia |
2 |
|
exendin-4 |
2 |
|
fine needle aspiration |
2 |
|
gata3 |
2 |
|
glp-1r |
2 |
|
melanoma |
2 |
|
metastasis |
2 |
|
metastatic carcinoma |
2 |
|
molecular classification |
2 |
|
ovary |
2 |
|
patient outcomes |
2 |
|
predictors |
2 |
|
prognosis |
2 |
|
psma |
2 |
|
sox10 |
2 |
|
steroid cell tumor |
2 |
|
steroid cell tumor not otherwise specified |
2 |
|
type 2 diabetes |
2 |
|
urine cytology |
2 |
|
adam10 |
1 |
|
adenoid cystic carcinoma |
1 |
|
akt pathway |
1 |
|
amyloid precursor protein |
1 |
|
anti-mda5 antibody |
1 |
|
anti-mda5 dermatomyositis |
1 |
|
artificial intelligence |
1 |
|
asco guideline |
1 |
|
aspiration cytology |
1 |
|
axillary lymph node metastasis |
1 |
|
basal marker |
1 |
|
biomarker |
1 |
|
blister |
1 |
|
breast aspirate |
1 |
|
breast cancers |
1 |
|
bronchial brushing |
1 |
|
bronchial cytology |
1 |
|
broncho-alveolar lavage |
1 |
|
bronchoscopy |
1 |
|
carcinoid |
1 |
|
carcinoma |
1 |
|
case report |
1 |
|
cd103+ |
1 |
|
cd163 |
1 |
|
cd206 |
1 |
|
cervical cytology |
1 |
|
ck15 |
1 |
|
convolutional neural network |
1 |
|
cutaneous mixed tumor |
1 |
|
cystic neutrophilic granulomatous mastitis |
1 |
|
cytokeratin 15 |
1 |
|
cytopathology |
1 |
|
dcis |
1 |
|
dek::aff2 |
1 |
|
dek::aff2 fusion-associated papillary squamous cell carcinoma |
1 |
|
dermatomyositis |
1 |
|
dermatopathology |
1 |
|
diagnosis |
1 |
|
digital cytopathology |
1 |
|
dna mismatch repair (mmr) |
1 |
|
ductal carcinoma in situ |
1 |
|
ductal carcinoma in-situ |
1 |
|
effusion |
1 |
|
effusion cytology |
1 |
|
effusion fluid |
1 |
|
egfr |
1 |
|
endometrioid adenocarcinoma |
1 |
|
endometrioid carcinoma |
1 |
|
endometrioid endometrial cancer |
1 |
|
epidermolysis bullosa dystrophica |
1 |
|
exfoliative cytology |
1 |
|
fibroadenoma |
1 |
|
fibroepithelial lesion |
1 |
|
fibrotic focus |
1 |
|
fine needle aspiration cytology |
1 |
|
fine-needle aspirate cytology |
1 |
|
fine-needle aspiration biopsy |
1 |
|
fluid cytology |
1 |
|
foxp3+ |
1 |
|
gcdfp-15 |
1 |
|
granuloma |
1 |
|
histology |
1 |
|
human epidermal growth factor receptor 2 |
1 |
|
idiopathic granulomatous mastitis |
1 |
|
immunocytochemistry |
1 |
|
immunofluorescence |
1 |
|
in situ hybridization |
1 |
|
inflammation |
1 |
|
ini1 |
1 |
|
international collaboration |
1 |
|
intraductal papilloma |
1 |
|
junctional |
1 |
|
keratinization |
1 |
|
lepidic adenocarcinoma |
1 |
|
liposarcoma |
1 |
|
liver abscess |
1 |
|
long-term survival |
1 |
|
lung |
1 |
|
machine learning |
1 |
|
malignant ascites |
1 |
|
mammaglobin |
1 |
|
mediastinal teratoma |
1 |
|
melanin |
1 |
|
melanotic oncocytic metasplasia |
1 |
|
meta-analysis |
1 |
|
metaplastic carcinoma |
1 |
|
microcalcification |
1 |
|
migration |
1 |
|
mitotic figure mimics |
1 |
|
mitotic figures |
1 |
|
mmr deficient (dmmr) |
1 |
|
mortality |
1 |
|
multiplex immunohistochemistry |
1 |
|
myoepithelium |
1 |
|
neoadjuvant chemotherapy |
1 |
|
neuroendocrine neoplasm |
1 |
|
neutrophil–lymphocyte ratio |
1 |
|
nodal metastasis |
1 |
|
number needed to diagnose |
1 |
|
oestrogen receptor |
1 |
|
oncocytic metaplasia |
1 |
|
papillary |
1 |
|
papillary carcinoma |
1 |
|
papillary morphology |
1 |
|
papillary thyroid carcinoma |
1 |
|
patients’ survival |
1 |
|
pemphigus |
1 |
|
pemphigus vegetans |
1 |
|
peritoneal fluid |
1 |
|
phyllodes tumour |
1 |
|
pleomorphic adenoma |
1 |
|
prame |
1 |
|
proliferation |
1 |
|
recurrence |
1 |
|
renal cell carcinoma |
1 |
|
risk assessment |
1 |
|
salivary gland tumor |
1 |
|
sebaceous carcinoma |
1 |
|
sebaceous lesion |
1 |
|
simplex |
1 |
|
sinonasal carcinoma |
1 |
|
smarca4 |
1 |
|
smarcb1-deficient sinonasal carcinoma |
1 |
|
social media |
1 |
|
soft tissue cytology |
1 |
|
spindle cell |
1 |
|
sputum cytology |
1 |
|
squamous cell carcinoma |
1 |
|
squamous morule |
1 |
|
stromal response |
1 |
|
systematic review |
1 |
|
targeted therapy |
1 |
|
the paris system for reporting urine cytology |
1 |
|
thyroid |
1 |
|
trichoblastic carcinosarcoma |
1 |
|
triple negative breast cancer |
1 |
|
trps1 |
1 |
|
tubular adenoma |
1 |
|
tumor infiltrating lymphocytes |
1 |
|
tumor microenvironment |
1 |
|
tumor-associated macrophage |
1 |
|
tumor-infiltrating lymphocytes |
1 |
|
tumour-associated macrophages |
1 |
|
tumour-infiltrating lymphocytes |
1 |
|
urinary tract pathology |
1 |
|
urine |
1 |
|
urothelial cancer |
1 |
|
urothelial carcinoma |
1 |
|
vaginal carcinosarcoma |
1 |
|
virtual multiplex immunohistochemistry |
1 |
|
wt1 |
1 |
|
yokohama system |
1 |
